Support for criticism of GPhC over handling of antisemitism

I refer to the letter by Jonathan Hoffman and Graham Phillips (The GPhc did not address antisemitism) and I wish to add my support to the detailed criticisms of the General Pharmaceutical Council on this matter.

The inadequate response of our respected and learned body, in this case, cannot be overlooked. I await an outcome that better reflects the evidence, testimonies and standards that have been well documented.

Gary Boorman, member, Royal Pharmaceutical Society